Difference between revisions of "Sapacitabine (CS-682)"

Revision as of 15:03, 17 August 2018

Pyrimidine analogue

Kantarjian H, Faderl S, Garcia-Manero G, Luger S, Venugopal P, Maness L, Wetzler M, Coutre S, Stock W, Claxton D, Goldberg SL, Arellano M, Strickland SA, Seiter K, Schiller G, Jabbour E, Chiao J, Plunkett W. Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. Lancet Oncol. 2012 Nov;13(11):1096-104. Epub 2012 Oct 15. link to original article link to PMC article PubMed

@@ Line 4: / Line 4: @@
 ==Preliminary results==
 ===[[Acute myeloid leukemia]]===
-# Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, Stuart L Goldberg, Martha Arellano, Stephen A Strickland, Karen Seiter, Gary Schiller, Elias Jabbour, Judy Chiao, William Plunkett, Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study, The Lancet Oncology, Volume 13, Issue 11, November 2012, Pages 1096-1104, ISSN 1470-2045, 10.1016/S1470-2045(12)70436-9. [http://www.sciencedirect.com/science/article/pii/S1470204512704369 link to article]
+# Kantarjian H, Faderl S, Garcia-Manero G, Luger S, Venugopal P, Maness L, Wetzler M, Coutre S, Stock W, Claxton D, Goldberg SL, Arellano M, Strickland SA, Seiter K, Schiller G, Jabbour E, Chiao J, Plunkett W. Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. Lancet Oncol. 2012 Nov;13(11):1096-104. Epub 2012 Oct 15. [https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(12)70436-9/fulltext link to original article] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004358/ link to PMC article] [https://www.ncbi.nlm.nih.gov/pubmed/23075701 PubMed]
 [[Category:Drugs]]
-[[Category:Chemotherapy]]
 [[Category:Oral medications]]